Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Treatment Options in Psychiatry
Erschienen in: Current Treatment Options in Psychiatry 4/2015

01.12.2015 | Anxiety, Obsessive Compulsive and Related Disorders (B Brennan and D Dougherty, Section Editors)

Review of Psychopharmacological Approaches for Trichotillomania and Other Body-Focused Behaviors

verfasst von: Jon E. Grant, J.D., M.D., M.P.H.

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Opinion statement

N-acetyl cysteine (NAC) is a safe, generally well-tolerated option for these disorders, and so I usually suggest a trial of NAC. If after 3 months and no response, I consider other options. If the person has urges to pull or pick and they have first-degree relatives with addictions, then I suggest a trial of naltrexone. If they have significant anxiety or depression co-occurring with the pulling, I often suggest clomipramine as a possible treatment for both conditions. In the case of skin picking with co-occurring depression or anxiety, I recommend a selective serotonin reuptake inhibitor (SSRI). Although we only have open-label data to support its use, I often use dronabinol in individuals who pick or pull most of the time unconsciously. Finally, I might suggest an antipsychotic for some people who have failed all else. Due to the side effects of antipsychotic medications, I use these only as a last resort.
Literatur
1.
Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry. 1991;52(10):415–7.PubMed
2.
King RA, Zohar AH, Ratzoni G, Binder M, Kron S, Dycian A, et al. An epidemiological study of trichotillomania in Israeli adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:1212–5.CrossRefPubMed
3.
Duke DC, Bodzin DK, Tavares P, Geffken GR, Storch EA. The phenomenology of hairpulling in a community sample. J Anxiety Disord. 2009;23(8):118–1125.
4.
Hayes SL, Storch EA, Berlanga L. Skin picking behaviors: an examination of the prevalence and severity in a community sample. J Anxiety Disord. 2009;23:314–9.CrossRefPubMed
5.
Keuthen NJ, Koran LM, Aboujaoude E, Large MD, Serpe RT. The prevalence of pathological skin picking in US adults. Compr Psychiatry. 2010;51:183–6.CrossRefPubMed
6.
Leibovici V, Murad S, Cooper-Kazaz R, Tetro T, Keuthen NJ, Hadayer N, et al. Excoriation (skin picking) disorder in Israeli University students: prevalence and associated mental health correlates. Gen Hosp Psychiatry. 2014;36(6):686–9.CrossRefPubMed
7.
Diefenbach GJ, Tolin DF, Hannan S, Crocetto J, Worhunsky P. Trichotillomania: impact on psychosocial functioning and quality of life. Behav Res Ther. 2005;43(7):869–84.CrossRefPubMed
8.
Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder. Am J Psychiatry. 2012;169:1143–9.CrossRefPubMed
9.
Tucker BT, Woods DW, Flessner CA, Franklin SA, Franklin ME. The skin picking impact project: phenomenology, interference, and treatment utilization of pathological skin picking in a population-based sample. J Anxiety Disord. 2011;25:88–95.CrossRefPubMed
10.
Flessner CA, Woods DW. Phenomenological characteristics, social problems, and the economic impact associated with chronic skin picking. Behav Modif. 2006;30:944–63.CrossRefPubMed
11.
Odlaug BL, Grant JE. Clinical characteristics and medical complications of pathologic skin picking. Gen Hosp Psychiatry. 2008;30(1):61–6.CrossRefPubMed
12.
Gaillard M, Tranchart H. Images in clinical medicine. Trichobezoar. N Engl J Med. 2015;372(6), e8.CrossRefPubMed
13.
Lewin AB, Piacentini J, Flessner CA, Woods DW, Franklin ME, Keuthen NJ, et al. Stein DJ; TLC-SAB. Depression, anxiety, and functional impairment in children with trichotillomania. Depress Anxiety. 2009;26(6):521–7.PubMed
14.
Christenson GA, Mansueto CS. Trichotillomania: descriptive characteristics and phenomenology. In: Stein DJ, Christianson GA, Hollander E, editors. Trichotillomania. Washington, DC: American Psychiatric Press; 1999. p. 1–41.
15.
Odlaug BL, Grant JE. Pathologic skin picking. In: Grant JE, Stein DJ, Woods DW, Keuthen NJ, editors. Trichotillomania, skin picking and other body-focused repetitive behaviors. Washington DC: American Psychiatric Publishing, Inc; 2012. p. pp 21–41.
16.
Woods DW, Flessner CA, Franklin ME, Keuthen NJ, Goodwin RD, Stein DJ, et al. The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry. 2006;67:1877–88.CrossRefPubMed
17.
Garner JP, Thogerson CM, Dufour BD, Würbel H, Murray JD, Mench JA. Reverse-translational biomarker validation of abnormal repetitive behaviors in mice: an illustration of the 4P’s modeling approach. Behav Brain Res. 2011;219(2):189–96.PubMedCentralCrossRefPubMed
18.
Chen SK, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell. 2010;141(5):775–85.PubMedCentralCrossRefPubMed
19.
Camilla d’Angelo LS, Eagle DM, Grant JE, Fineberg NA, Robbins TW, Chamberlain SR. Animal models of obsessive-compulsive spectrum disorders. CNS Spectr. 2014;19(1):28–49.CrossRefPubMed
20.
Chamberlain SR, Odlaug BL, Boulougouris V, Fineberg NA, Grant JE. Trichotillomania: neurobiology and treatment. Neurosci Biobehav Rev. 2009;33(6):831–42.CrossRefPubMed
21.
Novak CE, Keuthen NJ, Stewart SE, Pauls DL. A twin concordance study of trichotillomania. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):944–9.CrossRefPubMed
22.
Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA Psychiatry. 2014;71(2):182–9.CrossRefPubMed
23.
Monzani B, Rijsdijk F, Cherkas L, et al. Prevalence and heritability of skin picking in an adult community sample: a twin study. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(5):605–10.CrossRefPubMed
24.
Keuthen NJ, Altenburger EM, Pauls D. A family study of trichotillomania and chronic hair pulling. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(2):167–74. This is the first detailed family study of trichotillomania using a control group.CrossRefPubMed
25.•
Odlaug BL, Chamberlain SR, Derbyshire KL, Leppink EW, Grant JE. Impaired response inhibition and excess cortical thickness as candidate endophenotypes for trichotillomania. J Psychiatr Res. 2014;59:167–73. This study reports evidence for a familial cognitive vulnerability to trichotillomania.CrossRefPubMed
26.••
Roos A, Grant JE, Fouche JP, Stein DJ, Lochner C. A comparison of brain volume and cortical thickness in excoriation (skin picking) disorder and trichotillomania (hair pulling disorder) in women. Behav Brain Res. 2015;279:255–8. First international comparison study of the biology of trichotillomania and skin picking.CrossRefPubMed
27.
White MP, Shirer WR, Molfino MJ, Tenison C, Damoiseaux JS, Greicius MD. Disordered reward processing and functional connectivity in trichotillomania: a pilot study. J Psychiatr Res. 2013;47(9):1264–72.CrossRefPubMed
28.
Chamberlain SR, Hampshire A, Menzies LA, Garyfallidis E, Grant JE, Odlaug BL, et al. Reduced brain white matter integrity in trichotillomania:a diffusion tensor imaging study. Arch Gen Psychiatry. 2010;67(9):965–71.CrossRefPubMed
29.
Grant JE, Odlaug BL, Hampshire A, Schreiber LR, Chamberlain SR. White matter abnormalities in skin picking disorder: a diffusion tensor imaging study. Neuropsychopharmacology. 2013;38(5):763–9.PubMedCentralCrossRefPubMed
30.
McGuire JF, Ung D, Selles RR, Rahman O, Lewin AB, Murphy TK, et al. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. J Psychiatr Res. 2014;58:76–83.CrossRefPubMed
31.
Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2013;11, CD007662.PubMed
32.
Ninan PT, Rothbaum BO, Marsteller FA, Knight BT, Eccard MB. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000;61(1):47–50.CrossRefPubMed
33.
van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand I, Hendriks GJ. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry. 2003;60(5):517–22.CrossRefPubMed
34.
Dougherty DD, Loh R, Jenike MA, Keuthen NJ. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both? J Clin Psychiatry. 2006;67:1086–92.CrossRefPubMed
35.
Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756–63.CrossRefPubMed
36.•
Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013;52(3):231–40. First pharmacological study in children.PubMedCentralCrossRefPubMed
37.
Panza KE, Pittenger C, Bloch MH. Age and gender correlates of pulling in pediatric trichotillomania. J Am Acad Child Adolesc Psychiatry. 2013;52(3):241–9.PubMedCentralCrossRefPubMed
38.
Asevedo E, Mendes AC, Berk M, Brietzke E. Systematic review of N-acetylcysteine in the treatment of addictions. Rev Bras Psiquiatr. 2014;36(2):168–75.CrossRefPubMed
39.
Dodman NH, Shuster L, White SD, Court MH, Parker D, Dixon R. Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs. J Am Vet Med Assoc. 1988;193(7):815–9.PubMed
40.••
Grant JE, Odlaug BL, Schreiber LR, Kim SW. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014;34(1):134–8. First pharmacological study to demonstrate the utility of subtyping individuals based on cognitive profiles.CrossRefPubMed
41.
Van Ameringen M, Mancini C, Patterson B, Bennett M, Oakman J. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;71(10):1336–43.CrossRefPubMed
42.
White MP, Koran LM. Open-label trial of aripiprazole in the treatment of trichotillomania. J Clin Psychopharmacol. 2011;31(4):503–6.CrossRefPubMed
43.
Grant JE, Odlaug BL, Chamberlain SR, Kim SW. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl). 2011;218(3):493–502.CrossRef
44.
Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989;321(8):497–501.CrossRefPubMed
45.
Christenson GA, Mackenzie TB, Mitchell JE, Callies AL. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991;148(11):1566–71.CrossRefPubMed
46.
Pigott TA, L’Heueux F, grady TA. Controlled comparison of clomipramine and fluoxetine in trichotillomania. In Abstracts of the 31st Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December, 1992, p.157.
47.
Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry. 1995;152(8):1192–6.CrossRefPubMed
48.
O’Sullivan RL, Christenson GA, Stein DJ. Pharmacotherapy of trichotillomania. In: Stein DJ, Christianson GA, Hollander E, editors. Trichotillomania. Washington, DC: American Psychiatric Press; 1999. p. pp 93–123.
49.
Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997;58(8):341–7.CrossRefPubMed
50.
Bloch MR, Elliott M, Thompson H, Koran LM. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics. 2001;42(4):314–9.CrossRefPubMed
51.
Arbabi M, Farnia V, Balighi K. Efficacy of citalopram in the treatment of pathological skin picking: a randomized double blind placebo controlled trial. Acta Med Iran. 2008;46:367–72.
52.
Grant JE, Odlaug BL, Chamberlain SR, Kim SW. A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010;30(4):396–403.PubMedCentralCrossRefPubMed
Metadaten
Titel
Review of Psychopharmacological Approaches for Trichotillomania and Other Body-Focused Behaviors
verfasst von
Jon E. Grant, J.D., M.D., M.P.H.
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Psychiatry / Ausgabe 4/2015
Elektronische ISSN: 2196-3061
DOI
https://doi.org/10.1007/s40501-015-0058-1

Weitere Artikel der Ausgabe 4/2015

Current Treatment Options in Psychiatry 4/2015 Zur Ausgabe

Eating and Other Impulse Control Disorders (J Grant, Section Editor)

Are Eating Disorders Related to Attention Deficit/Hyperactivity Disorder?

INVITED COMMENTARY ON DEPRESSION

A Review of Brain Stimulation Treatments for Late-Life Depression

Suicide (MS Goodman, Section Editor)

“Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?”

Suicide (MS Goodman, Section Editor)

Inpatient Cognitive Behavior Therapy Approaches for Suicide Prevention

Eating and Other Impulse Control Disorders (J Grant, Section Editor)

Eating Disorders and Their Relationship to Impulsivity

Suicide (MS Goodman, Section Editor)

Mobile Health Technologies for Suicide Prevention: Feature Review and Recommendations for Use in Clinical Care

Neu im Fachgebiet Psychiatrie

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise